MCL1 and neoplasm: Also IBC tumor samples showed amplifications in the following: MYC (8/32; 25%), CCND1 (7/32; 22%), ErbB2 (5/32; 16%), MCL1 (6/32; 19%), and FGFR1 (3/32; 9%).